Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Oncotherapy Science Inc patents

Recent patent applications related to Oncotherapy Science Inc. Oncotherapy Science Inc is listed as an Agent/Assignee. Note: Oncotherapy Science Inc may have other listings under different names/spellings. We're not affiliated with Oncotherapy Science Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Oncotherapy Science Inc-related inventors




Date Oncotherapy Science Inc patents (updated weekly) - BOOKMARK this page
08/10/17Cdca1 epitope peptides for th1 cells and vaccines containing the same
07/13/17Kif20a epitope peptides for th1 cells and vaccines containing the same
07/13/17Tomm34 peptides and vaccines including the same
12/22/16Hjurp peptides and vaccines including the same
11/24/16Neil3 peptides and vaccines including the same
10/27/16Topk peptides and vaccines including the same
09/22/16Cdca1 epitope peptides and vaccines containing the same
07/14/16Peptide vaccines for cancers expressing tumor-associated antigens
04/28/16Imp-3 epitope peptides for th1 cells and vaccines containing the same
04/14/16Melk epitope peptides and vaccines containing the same
01/14/16Kntc2 peptides and vaccines containing the same
12/31/15Tomm34 peptides and vaccines including the same
12/17/15Pharmaceutical composition containing peptides
11/19/151,5-naphthyridine derivatives and melk inhibitors containing the same
11/12/15Sema5b peptides and vaccines containing the same
11/05/15Method of inducing an immune response by administering wdrpuh epitope peptides
10/15/15Neil3 peptides and vaccines including the same
09/24/15Foxm1 peptide and medicinal agent comprising the same
08/20/15Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
07/09/15Cdca1 epitope peptides for th1 cells and vaccines containing the same
07/09/15Ly6k epitope peptides for th1 cells and vaccines containing the same
07/09/15Kif20a epitope peptides for th1 cells and vaccines containing the same
07/02/15Tricyclic compounds and pbk inhibitors containing the same
02/19/15Method for treating synovial sarcoma
01/15/15Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/16/14Smyd2 as a target gene for cancer therapy and diagnosis
09/11/14Hjurp peptides and vaccines including the same
09/04/14Peptide vaccines for cancers expressing tumor-associated antigens
08/14/14Genes and polypeptides relating to breast cancers
07/17/14C1orf59 peptides and vaccines including the same
07/03/14Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
06/26/14Sema5b peptides and vaccines including the same
05/22/14Peptide vaccines for cancers expressing tumor-associated antigens
05/22/14Melk epitope peptides and vaccines containing the same
05/15/14Methods of modulating smyd3 for treatment of cancer
04/03/14Suv39h2 as a target gene for cancer therapy and diagnosis
01/23/14Foxm1 peptide and medicinal agent comprising the same
11/28/13Wdrpuh epitope peptides and vaccines containing the same
11/21/13Wdhd1 peptides and vaccines including the same
08/08/13Suv420h1 and suv420h2 as target genes for cancer therapy and diagnosis
07/25/13Peptide vaccines for cancers expressing tumor-associated antigens
07/11/13Tricyclic compounds and pbk inhibitors containing the same
05/30/13Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
05/23/13Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
05/02/13Cdca5 peptides and vaccines including the same
04/18/13Ect2 peptides and vaccines including the same
04/04/13Breast cancer related gene znfn3a1
02/07/13Modified melk peptides and vaccines containing the same
01/31/13Kdr peptides and vaccines comprising the same
01/10/13Method of diagnosing bladder cancer
12/27/12Kdr peptides and vaccines comprising the same
12/20/12Peptide vaccines for cancers expressing tumor-associated antigens
12/06/12Imp-3 oligopeptides and vaccines including the same
11/22/12Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/15/12Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/08/12Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
08/23/12Gene and polypeptide relating to breast cancer
07/26/12Genes and polypeptides relating to human colon cancers
06/21/12Foxm1 peptides and vaccines containing the same
06/21/12Vaccine therapy for choroidal neovascularization
06/14/12Gene and protein relating to hepatocellular carcinoma and methods of use thereof
05/31/12Ttk peptides and vaccines including the same
05/24/12Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
05/24/12C6orf167 peptides and vaccines containing the same
05/03/12Vangl1 peptides and vaccines including the same
Patent Packs
04/19/12Neil3 peptides and vaccines including the same
03/08/12Fused imidazole derivative having ttk inhibitory action
02/23/12Jarid1b for target gene of cancer therapy and diagnosis
02/16/12Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
02/02/12Genes and polypeptides relating to human pancreatic cancers
01/26/12Breast cancer related gene rqcd1
01/26/12Hypoxia-inducible protein 2 (hig2), a diagnostic marker for clear cell renal cell carcinoma
01/26/12Method of diagnosing esophageal cancer
01/26/12Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis
01/19/12Method of diagnosing bladder cancer
01/12/12Tbc1d7 as tumor marker and therapeutic target for cancer
01/12/12Method of diagnosing breast cancer
01/05/12C1orf59 peptides and vaccines including the same
01/05/12Screening anti-lung or esophageal cancer compounds
12/29/11Ect2 oncogene as a therapeutic target and prognostic indicator for lung and esophageal cancer
Patent Packs
12/22/11Cancer related gene, lgn/gpsm2
12/08/11Nectin-4 for target genes of cancer therapy and diagnosis
12/08/11Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
12/01/11Wdrpuh epitope peptides and vaccines containing the same
12/01/11Methods for diagnosing or treating prostate cancer
11/17/11Inhbb epitope peptides and vaccines containing the same
10/27/11Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/27/11Screening and therapeutic nsclc targeting cdca1-kntc2 complex
10/27/11C12orf48 as a target gene for cancer therapy and diagnosis
10/13/11Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/11Pancreatic cancer related gene ttll4
09/29/11Method for treating or preventing bladder cancer using the depdc1 polypeptide
09/15/11Method for diagnosing non-small cell lung cancer
09/01/11Melk epitope peptides and vaccines containing the same
08/18/11Iqgap3 epitope peptides and vaccines containing the same
08/11/11Foxm1 peptide and medicinal agent comprising the same
08/04/11Mybl2 epitope peptides and vaccines containing the same
08/04/11Cdca1 epitope peptides and vaccines containing the same
08/04/11Benzoimidazole derivatives and glycogen synthase kinase-3 beta inhibitors containing the same
07/07/11Cdh3 peptide and medicinal agent comprising the same
06/30/11Cancer-related genes, cdca5, epha7, stk31 and wdhd1
06/30/11Oip5 as a target gene for cancer therapy and diagnosis
06/30/11Prmt1 for target genes of cancer therapy and diagnosis
06/23/11Cdca1 peptide and pharmaceutical agent comprising the same
06/23/11Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
06/09/11Genes and polypeptides relating to breast cancers
06/09/11Prostate cancer related gene styk1
04/28/11C2orf18 as target gene for cancer therapy and diagnosis
04/07/11Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
03/31/11Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker
Social Network Patent Pack
03/24/11Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
03/03/11Stat3 epitope peptides
02/03/11Method for treating synovial sarcoma
02/03/11Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
01/20/11Method for diagnosing non-small cell lung cancers by trna-dihydrouridine synthase activity of urlc8
11/18/10Genes and polypeptides relating to hepatocellular or colorectal carcinoma
11/18/10Prognostic markers and therapeutic targets for lung cancer
10/28/10Compositions and methods of treating cancer
09/30/10Gene and protein relating to hepatocellular carcinoma and methods of use thereof
08/12/10Hypoxia-inducible protein 2 (hig 2), a diagnostic marker for clear cell renal cell carcinoma
Patent Packs
07/22/10Screening and therapeutic nsclc targeting the cdca8-aurkb complex
07/22/10Methods of identifying agents that modulate methylation of vegfr1 by smyd3
07/08/10Method for diagnosing non-small cell lung cancer
04/15/10Foxp3 peptide vaccine
04/15/10Genes and polypeptides relating to human pancreatic cancers
02/18/10Peptide vaccines for cancers expressing tumor-associated antigens
02/04/10Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
01/21/10Genes and polypeptides relating to human colon cancers
12/17/09Nmu-ghsr1b/ntsr1 oncogenic signaling pathway as a therapeutic target for lung cancer
12/03/09Non-small cell lung cancer-related gene, anln, and its interaction with rhoa
11/19/09Method of diagnosing breast cancer
10/22/09Genes and polypeptides relating to breast cancers
10/08/09Kdr peptides and vaccines comprising the same
08/27/09Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
07/30/09Methods for damaging cells using effector functions of anti-epha4 antibodies
07/23/09Methods for treating lung cancers
07/02/09Methods for damaging cells using effector functions of anti-cdh3 antibodies
06/25/09Method for diagnosing pancreatic cancer
06/18/09Methods for damaging cells using effector functions of anti-gfra1 antibodies
02/05/09Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Oncotherapy Science Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Oncotherapy Science Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';